Living Machines: Microbial factories to produce nutrients and medicines on demand

About us

Elive Bio creates self-contained, bioregenerative life support systems that integrate food, oxygen, water, nutrition and pharmaceutical production, from resource constrained situations.
This paves the way for sustainable human presence not just on earth & its extreme environments, but far beyond Earth as well.
This convergence of synthetic biology & biomaterials that yields living machines, holds immense promise for the future of life including space travel and colonization.
EliveBio Inc. was founded by a team of successful entrepreneurs with decades of experience in synthetic biology and bio-pharmaceuticals.

Current Projects

InSitu Bionutrients:

Healthy human life needs several nutrients daily and supplements are not effectively bioavailable. Elive Bio offers an InSitu baker’s yeast that produces variety of nutrient precursors – the most vital of them being a spectrum of carotenoids, that can be produced “On Demand, On Site” within the human body to sustain life, both on and off earth.
This InSitu Yeast renders itself to produce these nutrients in a self-contained, resource constrained conditions, even in tougher environs of deep space or deep sea.

Mood elevation in extreme environments:

Tougher habitats imposes a stiff penalty on life, leading to stress. Elive Bio's miniature biofactories produces several natural mood elevators, presently in the human food chain. Some of these are from exotic spices such as saffron. This helps improve cognition, decision making and motor-neuron skills, which are crucial for humans to face and solve complex challenges - be it a nuclear submarine in deep sea or deep space faring crucible.

Live Anticancer Therapy

Advancements in cancer treatment, including targeted therapy and immunotherapy, offer hope for curing various cancer types. However, challenges persist, such as toxicity to normal tissues, deep tumor treatment difficulties, and drug resistance. Live tumor-targeting bacteria, engineered for controlled drug delivery, provide a promising solution. These bacteria can be used alone or in combination with other therapies to improve clinical outcomes, specifically targeting respiratory tract cancers.

EliveBio's Team

Murali Panchapagesa, Ph.D

- Founder

A serial entrepreneur with three decades of experience in synthetic biology and drug development with applications in pulmonary disorders.

Chitra Murali, M.Sc

- Co-Founder

A nutritionist with a keen interest in plant based compounds with therapeutic benefits for the holistic treatment of lifestyle diseases and terminal illnesses.

Shriram Raghavan, Ph.D

A computational biologist with over two decades of experience and a focus on advanced live biotherapeutics for terminal illnesses.

Stanley Goldman, Ph.D

An experienced synthetic biologist and biothreat defense expert. Pioneered the development of several vaccines and biological therapeutics. Previously associated with Maxygen, Phyllom, Navy Medical Research Center, Evolva and Fraunhofer.

Phillip Polakoff, MD

Advisor to the US Government on public health. Consulting professor at Stanford School of Medicine. Board member and guide to several startups.

Bobba Venkatadri, Ph.D

Partner at Ventureast, a leading life science investment firm, with experience in pharmaceutical organizations across the USA and Europe, including Cancer Genetics, J&J and Merck.

Residency

EliveBio believes in "Igniting Young minds" with a flexible residency program.
Interested candidates can reach out at : shriram@elivebio.com

Contact

Incorporated at:

16192, Coastal Highway, Lewes, Delaware 19958, County of Sussex, United States of America

Shriram Raghavan   shriram@elivebio.com
Follow us on